% alzhub.org library filter
% Source: https://alzhub.org/research?design=trial&access=free
% 129 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{zimmer2025-40063015,
  author  = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others},
  title   = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0065},
  pmid    = {40063015},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0065}
}

@article{salloway2022-34807243,
  author  = {Salloway, S. and Chalkias, S. and Barkhof, F. and Burkett, P. and Barakos, J. and Purcell, D. and Suhy, J. and Forrestal, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4161},
  pmid    = {34807243},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4161}
}

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{florian2023-36730056,
  author  = {Florian, H. and Wang, D. and Arnold, S. E. and Boada, M. and Guo, Q. and Jin, Z. and Zheng, H. and Fisseha, N. and others},
  title   = {{Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad024},
  pmid    = {36730056},
  url     = {https://doi.org/10.1093/brain/awad024}
}

@article{turner2015-26362286,
  author  = {Turner, R. S. and Thomas, R. G. and Craft, S. and van Dyck, C. H. and Mintzer, J. and Reynolds, B. A. and Brewer, J. B. and Rissman, R. A. and others},
  title   = {{A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000002035},
  pmid    = {26362286},
  url     = {https://doi.org/10.1212/wnl.0000000000002035}
}

@article{ostrowitzki2022-36121669,
  author  = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others},
  title   = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2909},
  pmid    = {36121669},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2909}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{swanson2021-33865446,
  author  = {Swanson, C. J. and Zhang, Y. and Dhadda, S. and Wang, J. and Kaplow, J. and Lai, R. Y. K. and Lannfelt, L. and Bradley, H. and others},
  title   = {{A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00813-8},
  pmid    = {33865446},
  url     = {https://doi.org/10.1186/s13195-021-00813-8}
}

@article{cummings2025-39780249,
  author  = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others},
  title   = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01666-7},
  pmid    = {39780249},
  url     = {https://doi.org/10.1186/s13195-024-01666-7}
}

@article{green2009-20009055,
  author  = {Green, R. C. and Schneider, L. S. and Amato, D. A. and Beelen, A. P. and Wilcock, G. and Swabb, E. A. and Zavitz, K. H. and {Tarenflurbil Phase 3 Study Group}},
  title   = {{Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2009},
  doi     = {10.1001/jama.2009.1866},
  pmid    = {20009055},
  url     = {https://doi.org/10.1001/jama.2009.1866}
}

@article{vandyck2023-36449413,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and others},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2212948},
  pmid    = {36449413},
  url     = {https://doi.org/10.1056/nejmoa2212948}
}

@article{mintun2021-33720637,
  author  = {Mintun, M. A. and Lo, A. C. and Duggan Evans, C. and Wessels, A. M. and Ardayfio, P. A. and Andersen, S. W. and Shcherbinin, S. and Sparks, J. and others},
  title   = {{Donanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2021},
  doi     = {10.1056/nejmoa2100708},
  pmid    = {33720637},
  url     = {https://doi.org/10.1056/nejmoa2100708}
}

@article{edison2025-41326666,
  author  = {Edison, P. and Femminella, G. D. and Ritchie, C. and Nowell, J. and Holmes, C. and Walker, Z. and Ridha, B. and Raza, S. and Livingston, N. R. and Frangou, E. and others},
  title   = {{Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-04106-7},
  pmid    = {41326666},
  url     = {https://doi.org/10.1038/s41591-025-04106-7}
}

@article{honig2024-38730496,
  author  = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others},
  title   = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01441-8},
  pmid    = {38730496},
  url     = {https://doi.org/10.1186/s13195-024-01441-8}
}

@article{wessels2020-31764959,
  author  = {Wessels, A. M. and Tariot, P. N. and Zimmer, J. A. and Selzler, K. J. and Bragg, S. M. and Andersen, S. W. and Landry, J. and Krull, J. H. and others},
  title   = {{Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3988},
  pmid    = {31764959},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3988}
}

@article{teng2022-35696185,
  author  = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others},
  title   = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.1375},
  pmid    = {35696185},
  url     = {https://doi.org/10.1001/jamaneurol.2022.1375}
}

@article{craft2020-32568367,
  author  = {Craft, S. and Raman, R. and Chow, T. W. and Rafii, M. S. and Sun, C. K. and Rissman, R. A. and Donohue, M. C. and Brewer, J. B. and others},
  title   = {{Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.1840},
  pmid    = {32568367},
  url     = {https://doi.org/10.1001/jamaneurol.2020.1840}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{wang2025-40172303,
  author  = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others},
  title   = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70062},
  pmid    = {40172303},
  url     = {https://doi.org/10.1002/alz.70062}
}

@article{lu2025-41082199,
  author  = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others},
  title   = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3869},
  pmid    = {41082199},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3869}
}

@article{shcherbinin2022-36094645,
  author  = {Shcherbinin, S. and Evans, C. D. and Lu, M. and Andersen, S. W. and Pontecorvo, M. J. and Willis, B. A. and Gueorguieva, I. and Hauck, P. M. and others},
  title   = {{Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2793},
  pmid    = {36094645},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2793}
}

@article{rajji2025-40133524,
  author  = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others},
  title   = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03569-y},
  pmid    = {40133524},
  url     = {https://doi.org/10.1038/s41591-025-03569-y}
}

@article{salloway2009-19923550,
  author  = {Salloway, S. and Sperling, R. and Gilman, S. and Fox, N. C. and Blennow, K. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181c67808},
  pmid    = {19923550},
  url     = {https://doi.org/10.1212/wnl.0b013e3181c67808}
}

@article{sims2023-37459141,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and others},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  doi     = {10.1001/jama.2023.13239},
  pmid    = {37459141},
  url     = {https://doi.org/10.1001/jama.2023.13239}
}

@article{cummings2018-29695589,
  author  = {Cummings, J. L. and Cohen, S. and van Dyck, C. H. and Brody, M. and Curtis, C. and Cho, W. and Ward, M. and Friesenhahn, M. and others},
  title   = {{ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005550},
  pmid    = {29695589},
  url     = {https://doi.org/10.1212/wnl.0000000000005550}
}

@article{monteiro2023-37643887,
  author  = {Monteiro, C. and Toth, B. and Brunstein, F. and Bobbala, A. and Datta, S. and Ceniceros, R. and Sanabria Bohorquez, S. M. and Anania, V. G. and others},
  title   = {{Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207663},
  pmid    = {37643887},
  url     = {https://doi.org/10.1212/wnl.0000000000207663}
}

@article{xiao2021-33731209,
  author  = {Xiao, S. and Chan, P. and Wang, T. and Hong, Z. and Wang, S. and Kuang, W. and He, J. and Pan, X. and others},
  title   = {{A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00795-7},
  pmid    = {33731209},
  url     = {https://doi.org/10.1186/s13195-021-00795-7}
}

@article{ornish2024-38849944,
  author  = {Ornish, D. and Madison, C. and Kivipelto, M. and Kemp, C. and McCulloch, C. E. and Galasko, D. and Artz, J. and Rentz, D. and others},
  title   = {{Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01482-z},
  pmid    = {38849944},
  url     = {https://doi.org/10.1186/s13195-024-01482-z}
}

@article{prins2021-34044875,
  author  = {Prins, N. D. and Harrison, J. E. and Chu, H. M. and Blackburn, K. and Alam, J. J. and Scheltens, P. and {REVERSE-SD Study Investigators}},
  title   = {{A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00843-2},
  pmid    = {34044875},
  url     = {https://doi.org/10.1186/s13195-021-00843-2}
}

@article{tsai2020-31710340,
  author  = {Tsai, R. M. and Miller, Z. and Koestler, M. and Rojas, J. C. and Ljubenkov, P. A. and Rosen, H. J. and Rabinovici, G. D. and Fagan, A. M. and others},
  title   = {{Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3812},
  pmid    = {31710340},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3812}
}

@article{baker2025-40271888,
  author  = {Baker, L. D. and Pa, J. A. and Katula, J. A. and Aslanyan, V. and Salmon, D. P. and Jacobs, D. M. and Chmelo, E. A. and Hodge, H. and Morrison, R. and Matthews, G. and others},
  title   = {{Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.14586},
  pmid    = {40271888},
  url     = {https://doi.org/10.1002/alz.14586}
}

@article{devanand2026-41405855,
  author  = {Devanand, D P and Wisniewski, Thomas and Razlighi, Qolamreza and Qian, Min and Wei, Renjie and Andrews, Howard F and Acosta, Edward P and Bell, Karen L and others},
  title   = {{Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2025.21738},
  pmid    = {41405855},
  url     = {https://doi.org/10.1001/jama.2025.21738}
}

@article{fleisher2024-38386949,
  author  = {Fleisher, A. S. and Munsie, L. M. and Perahia, D. G. S. and Andersen, S. W. and Higgins, I. A. and Hauck, P. M. and Lo, A. C. and Sims, JR. and others},
  title   = {{Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000208061},
  pmid    = {38386949},
  url     = {https://doi.org/10.1212/wnl.0000000000208061}
}

@article{sha2019-30383097,
  author  = {Sha, S. J. and Deutsch, G. K. and Tian, L. and Richardson, K. and Coburn, M. and Gaudioso, J. L. and Marcal, T. and Solomon, E. and others},
  title   = {{Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2018.3288},
  pmid    = {30383097},
  url     = {https://doi.org/10.1001/jamaneurol.2018.3288}
}

@article{mori2012-22829268,
  author  = {Mori, E. and Ikeda, M. and Kosaka, K. and {Donepezil-DLB Study Investigators}},
  title   = {{Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial}},
  journal = {Annals of neurology},
  year    = {2012},
  doi     = {10.1002/ana.23557},
  pmid    = {22829268},
  url     = {https://doi.org/10.1002/ana.23557}
}

@article{cummings2026-41865758,
  author  = {Cummings, Jeffrey L and Atri, Alireza and Sano, Mary and Zetterberg, Henrik and Scheltens, Philip and Knop, Filip K and Johannsen, Peter and Wichmann, Christian Ahmad and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{mummery2023-37095250,
  author  = {Mummery, C. J. and Börjesson-Hanson, A. and Blackburn, D. J. and Vijverberg, E. G. B. and De Deyn, P. P. and Ducharme, S. and Jonsson, M. and Schneider, A. and Rinne, J. O. and Ludolph, A. C. and Bodenschatz, R. and Kordasiewicz, H. and others},
  title   = {{Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial}},
  journal = {Nature Medicine},
  year    = {2023},
  doi     = {10.1038/s41591-023-02326-3},
  pmid    = {37095250},
  url     = {https://doi.org/10.1038/s41591-023-02326-3}
}

@article{singh2024-39432286,
  author  = {Singh, S. and Li, X. and Cocoros, N. M. and Antonelli, M. T. and Avula, R. and Crawford, S. L. and Dashevsky, I. and Fouayzi, H. and others},
  title   = {{High-Risk Medications in Persons Living With Dementia: A Randomized Clinical Trial}},
  journal = {JAMA internal medicine},
  year    = {2024},
  doi     = {10.1001/jamainternmed.2024.5632},
  pmid    = {39432286},
  url     = {https://doi.org/10.1001/jamainternmed.2024.5632}
}

@article{curtis2015-25622185,
  author  = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others},
  title   = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.4144},
  pmid    = {25622185},
  url     = {https://doi.org/10.1001/jamaneurol.2014.4144}
}

@article{long2024-39444037,
  author  = {Long, H. and Simmons, A. and Mayorga, A. and Burgess, B. and Nguyen, T. and Budda, B. and Rychkova, A. and Rhinn, H. and others},
  title   = {{Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01599-1},
  pmid    = {39444037},
  url     = {https://doi.org/10.1186/s13195-024-01599-1}
}

@article{sevigny2024-38745011,
  author  = {Sevigny, J. and Uspenskaya, O. and Heckman, L. D. and Wong, L. C. and Hatch, D. A. and Tewari, A. and Vandenberghe, R. and Irwin, D. J. and others},
  title   = {{Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02973-0},
  pmid    = {38745011},
  url     = {https://doi.org/10.1038/s41591-024-02973-0}
}

@article{morato2023-37012306,
  author  = {Morató, X. and Marquié, M. and Tartari, J. P. and Lafuente, A. and Abdelnour, C. and Alegret, M. and Jofresa, S. and Buendía, M. and others},
  title   = {{A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress}},
  journal = {Scientific reports},
  year    = {2023},
  doi     = {10.1038/s41598-023-32515-6},
  pmid    = {37012306},
  url     = {https://doi.org/10.1038/s41598-023-32515-6}
}

@article{cantoni2025-41359335,
  author  = {Cantoni, V. and Casula, E. P. and Tarantino, B. and Cupidi, C. and Huber, N. and Altomare, D. and Premi, E. and Zummo, E. and others},
  title   = {{Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2025},
  doi     = {10.1001/jamanetworkopen.2025.46556},
  pmid    = {41359335},
  url     = {https://doi.org/10.1001/jamanetworkopen.2025.46556}
}

@article{coleman2025-39862881,
  author  = {Coleman, K. K. L. and Berry, S. and Cummings, J. and Hsiung, G. R. and Laforce, R. and Huey, E. and Ducharme, S. and Tartaglia, M. C. and Mendez, M. F. and Onyike, C. and others},
  title   = {{Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial}},
  journal = {The Lancet Neurology},
  year    = {2025},
  doi     = {10.1016/S1474-4422(24)00456-3},
  pmid    = {39862881},
  url     = {https://doi.org/10.1016/S1474-4422(24)00456-3}
}

@article{salloway2011-21917766,
  author  = {Salloway, S. and Sperling, R. and Keren, R. and Porsteinsson, A. P. and van Dyck, C. H. and Tariot, P. N. and Gilman, S. and Arnold, D. and others},
  title   = {{A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e3182309fa5},
  pmid    = {21917766},
  url     = {https://doi.org/10.1212/wnl.0b013e3182309fa5}
}

@article{rafii2018-29582053,
  author  = {Rafii, M. S. and Tuszynski, M. H. and Thomas, R. G. and Barba, D. and Brewer, J. B. and Rissman, R. A. and Siffert, J. and Aisen, P. S. and others},
  title   = {{Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2018},
  doi     = {10.1001/jamaneurol.2018.0233},
  pmid    = {29582053},
  url     = {https://doi.org/10.1001/jamaneurol.2018.0233}
}

@article{schneider2019-31492718,
  author  = {Schneider, L. S. and Geffen, Y. and Rabinowitz, J. and Thomas, R. G. and Schmidt, R. and Ropele, S. and Weinstock, M. and {Ladostigil Study Group}},
  title   = {{Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000008239},
  pmid    = {31492718},
  url     = {https://doi.org/10.1212/wnl.0000000000008239}
}

@article{saito2023-38048134,
  author  = {Saito, S. and Suzuki, K. and Ohtani, R. and Maki, T. and Kowa, H. and Tachibana, H. and Washida, K. and Kawabata, N. and others},
  title   = {{Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2023.44938},
  pmid    = {38048134},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.44938}
}

@article{edwards2023-37902726,
  author  = {Edwards, A. L. and Collins, J. A. and Junge, C. and Kordasiewicz, H. and Mignon, L. and Wu, S. and Li, Y. and Lin, L. and others},
  title   = {{Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.3861},
  pmid    = {37902726},
  url     = {https://doi.org/10.1001/jamaneurol.2023.3861}
}

@article{sharma2026-41985132,
  author  = {Sharma, Mukul and Dong, Qiang and Hirano, Teruyuki and Kasner, Scott Eric and Saver, Jeffrey L. and Masjuan, Jaime and Demchuk, Andrew M. and Cordonnier, Charlotte and others},
  title   = {{Asundexian for Secondary Stroke Prevention}},
  journal = {New England Journal of Medicine},
  year    = {2026},
  doi     = {10.1056/nejmoa2513880},
  pmid    = {41985132},
  url     = {https://doi.org/10.1056/nejmoa2513880}
}

@article{liu2025-40507855,
  author  = {Liu, X. and Baxley, S. and Hebron, M. and Turner, R. S. and Moussa, C.},
  title   = {{Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease}},
  journal = {International journal of molecular sciences},
  year    = {2025},
  doi     = {10.3390/ijms26115044},
  pmid    = {40507855},
  url     = {https://doi.org/10.3390/ijms26115044}
}

@article{berry2023-37040116,
  author  = {Berry, D. A. and Dhadda, S. and Kanekiyo, M. and Li, D. and Swanson, C. J. and Irizarry, M. and Kramer, L. D. and Berry, S. M.},
  title   = {{Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2023.7230},
  pmid    = {37040116},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.7230}
}

@article{liu2015-26208959,
  author  = {Liu, E. and Schmidt, M. E. and Margolin, R. and Sperling, R. and Koeppe, R. and Mason, N. S. and Klunk, W. E. and Mathis, C. A. and others},
  title   = {{Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000001877},
  pmid    = {26208959},
  url     = {https://doi.org/10.1212/wnl.0000000000001877}
}

@article{burstein2014-24423155,
  author  = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.},
  title   = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}},
  journal = {BMC neurology},
  year    = {2014},
  doi     = {10.1186/1471-2377-14-12},
  pmid    = {24423155},
  url     = {https://doi.org/10.1186/1471-2377-14-12}
}

@article{fleisher2026-42441396,
  author  = {Fleisher, Adam S and Munsie, Leanne and Mancini, Michele and Cheng, Yun-Ju and Guo, Jiaying and Nuthall, Hugh and Otero, Diana Svaldi and Kotari, Vikas and others},
  title   = {{Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2026.12768},
  pmid    = {42441396},
  url     = {https://doi.org/10.1001/jama.2026.12768}
}

@article{mathioudakis2025-41144242,
  author  = {Mathioudakis, Nestoras Nicolas and Lalani, Benjamin and Abusamaan, Mohammed S. and Alderfer, Mary Ellen and Alver, Defne and Dobs, Adrian and Kane, Brian and others},
  title   = {{An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program}},
  journal = {JAMA},
  year    = {2025},
  doi     = {10.1001/jama.2025.19563},
  pmid    = {41144242},
  url     = {https://doi.org/10.1001/jama.2025.19563}
}

@article{vandyck2025-41355080,
  author  = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.},
  title   = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70905},
  pmid    = {41355080},
  url     = {https://doi.org/10.1002/alz.70905}
}

@article{atri2026-42128444,
  author  = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.},
  title   = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}},
  journal = {Neurology: Clinical Practice},
  year    = {2026},
  doi     = {10.1212/CPJ.0000000000200621},
  pmid    = {42128444},
  url     = {https://doi.org/10.1212/CPJ.0000000000200621}
}

@article{davidson2026-41109840,
  author  = {Davidson, M. H. and Szarek, M. and Scheltens, P. and Vijverberg, E. and Hsieh, A. and Ditmarsch, M. and Kling, D. and Curcio, D. and others},
  title   = {{Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2025.100394},
  pmid    = {41109840},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100394}
}

@article{johnson2013-23375563,
  author  = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others},
  title   = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.10.007},
  pmid    = {23375563},
  url     = {https://doi.org/10.1016/j.jalz.2012.10.007}
}

@article{sperling2012-22305802,
  author  = {Sperling, R. and Salloway, S. and Brooks, D. J. and Tampieri, D. and Barakos, J. and Fox, N. C. and Raskind, M. and Sabbagh, M. and others},
  title   = {{Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis}},
  journal = {The Lancet. Neurology},
  year    = {2012},
  doi     = {10.1016/s1474-4422(12)70015-7},
  pmid    = {22305802},
  url     = {https://doi.org/10.1016/s1474-4422(12)70015-7}
}

@article{nakamura2024-39369280,
  author  = {Nakamura, Y. and Adachi, J. and Hirota, N. and Iba, K. and Shimizu, K. and Nakai, M. and Takahashi, K. and Mori, N.},
  title   = {{Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2024},
  doi     = {10.1002/alz.14282},
  pmid    = {39369280},
  url     = {https://doi.org/10.1002/alz.14282}
}

@article{rosenberg2025-41350162,
  author  = {Rosenberg, P. B. and Amjad, H. and Burhanullah, H. and Nowrangi, M. and Vandrey, R. and Pierre, M. J. and Outen, J. D. and Schultz, M. and Marano, C. and Agronin, M. and others},
  title   = {{A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease}},
  journal = {The American Journal of Geriatric Psychiatry},
  year    = {2025},
  doi     = {10.1016/j.jagp.2025.10.011},
  pmid    = {41350162},
  url     = {https://doi.org/10.1016/j.jagp.2025.10.011}
}

@article{wischik2026-41570392,
  author  = {Wischik, C. M. and Stefanacci, R. and Bentham, P. and Gauthier, S. and Zetterberg, H. and Wilcock, G. K. and Froelich, L. and Burns, A. and MacSweeney, E. and Ballard, C. and others},
  title   = {{Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100480},
  pmid    = {41570392},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100480}
}

@article{yassine2026-42315445,
  author  = {Yassine, Hussein N and Pour, Sara Ghasem and Juarez, Marlene and Arrelanas, Isabella C and Ali, Nada and Dikeman, Dante and Sanchez, Ashley and Park, Jackson and others},
  title   = {{CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial}},
  journal = {EBioMedicine},
  year    = {2026},
  doi     = {10.1016/j.ebiom.2026.106316},
  pmid    = {42315445},
  url     = {https://doi.org/10.1016/j.ebiom.2026.106316}
}

@article{kessler2008-18972062,
  author  = {Kessler, H. and Pajonk, F. G. and Bach, D. and Schneider-Axmann, T. and Falkai, P. and Herrmann, W. and Multhaup, G. and Wiltfang, J. and others},
  title   = {{Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial}},
  journal = {Journal of neural transmission (Vienna, Austria : 1996)},
  year    = {2008},
  doi     = {10.1007/s00702-008-0136-2},
  pmid    = {18972062},
  url     = {https://doi.org/10.1007/s00702-008-0136-2}
}

@article{ossenkoppele2022-35643092,
  author  = {Ossenkoppele, R. and van der Kant, R. and Hansson, O.},
  title   = {{Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(22)00168-5},
  pmid    = {35643092},
  url     = {https://doi.org/10.1016/s1474-4422(22)00168-5}
}

@article{liuseifert2015-26402769,
  author  = {Liu-Seifert, H. and Siemers, E. and Price, K. and Han, B. and Selzler, K. J. and Henley, D. and Sundell, K. and Aisen, P. and others},
  title   = {{Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142508},
  pmid    = {26402769},
  url     = {https://doi.org/10.3233/jad-142508}
}

@article{mohamed2012-21939611,
  author  = {Mohamed, S. and Rosenheck, R. and Lyketsos, C. G. and Kaczynski, R. and Sultzer, D. L. and Schneider, L. S.},
  title   = {{Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease}},
  journal = {The Journal of clinical psychiatry},
  year    = {2012},
  doi     = {10.4088/jcp.10m06574},
  pmid    = {21939611},
  url     = {https://doi.org/10.4088/jcp.10m06574}
}

@article{wang2019-31488882,
  author  = {Wang, X. and Sun, G. and Feng, T. and Zhang, J. and Huang, X. and Wang, T. and Xie, Z. and Chu, X. and others},
  title   = {{Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression}},
  journal = {Cell research},
  year    = {2019},
  doi     = {10.1038/s41422-019-0216-x},
  pmid    = {31488882},
  url     = {https://doi.org/10.1038/s41422-019-0216-x}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{loomis2024-38165296,
  author  = {Loomis, S. J. and Miller, R. and Castrillo-Viguera, C. and Umans, K. and Cheng, W. and O'Gorman, J. and Hughes, R. and Budd Haeberlein, S. and others},
  title   = {{Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000207919},
  pmid    = {38165296},
  url     = {https://doi.org/10.1212/wnl.0000000000207919}
}

@article{black2010-20505438,
  author  = {Black, R. S. and Sperling, R. A. and Safirstein, B. and Motter, R. N. and Pallay, A. and Nichols, A. and Grundman, M.},
  title   = {{A single ascending dose study of bapineuzumab in patients with Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2010},
  doi     = {10.1097/wad.0b013e3181c53b00},
  pmid    = {20505438},
  url     = {https://doi.org/10.1097/wad.0b013e3181c53b00}
}

@article{silveira2025-40587145,
  author  = {Silveira, C. R. A. and Coleman, K. K. L. and Borron, K. and Tirona, R. G. and Rupar, C. A. and Zou, G. and Hegele, R. A. and Wellington, C. and others},
  title   = {{Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.1687},
  pmid    = {40587145},
  url     = {https://doi.org/10.1001/jamaneurol.2025.1687}
}

@article{sabbagh2023-37695107,
  author  = {Sabbagh, M. N. and Mathew, P. and Blau, A.},
  title   = {{A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2023},
  doi     = {10.1097/wad.0000000000000578},
  pmid    = {37695107},
  url     = {https://doi.org/10.1097/wad.0000000000000578}
}

@article{chen2025-40189473,
  author  = {Chen, Christopher and Katayama, Sadao and Lee, Jae Hong and Lee, Jun-Young and Nakagawa, Masaki and Torii, Kentaro and Ogawa, Tomoo and Dash, Amitabh and others},
  title   = {{Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100160},
  pmid    = {40189473},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100160}
}

@article{portron2020-31883703,
  author  = {Portron, A. and Jordan, P. and Draper, K. and Muenzer, C. and Dickerson, D. and van Iersel, T. and Hofmann, C.},
  title   = {{A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers}},
  journal = {Clinical therapeutics},
  year    = {2020},
  doi     = {10.1016/j.clinthera.2019.11.015},
  pmid    = {31883703},
  url     = {https://doi.org/10.1016/j.clinthera.2019.11.015}
}

@article{dicaro2026-41943055,
  author  = {Di Caro, V. and Cho, E. and Thiel, J. and Lizama, B. N. and Koel-Simmelink, M. J. A. and Pandey, K. and Duong, D. and Seyfried, N. T. and others},
  title   = {{Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2026},
  doi     = {10.1186/s13195-026-02025-4},
  pmid    = {41943055},
  url     = {https://doi.org/10.1186/s13195-026-02025-4}
}

@article{wong2010-20501908,
  author  = {Wong, D. F. and Rosenberg, P. B. and Zhou, Y. and Kumar, A. and Raymont, V. and Ravert, H. T. and Dannals, R. F. and Nandi, A. and others},
  title   = {{In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2010},
  doi     = {10.2967/jnumed.109.069088},
  pmid    = {20501908},
  url     = {https://doi.org/10.2967/jnumed.109.069088}
}

@article{haroon2024-39058809,
  author  = {Haroon, J. and Jordan, K. and Mahdavi, K. and Rindner, E. and Becerra, S. and Surya, JR. and Zielinski, M. and Venkatraman, V. and others},
  title   = {{A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias}},
  journal = {Medicine},
  year    = {2024},
  doi     = {10.1097/md.0000000000039027},
  pmid    = {39058809},
  url     = {https://doi.org/10.1097/md.0000000000039027}
}

@article{aumont2025-40880087,
  author  = {Aumont, E. and Therriault, J. and Kwan, A. T. H. and Carello-Collar, G. and Arfaie, S. and Hall, B. J. and Ferrari-Souza, J. P. and Woo, M. S. and others},
  title   = {{The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease}},
  journal = {JAMA network open},
  year    = {2025},
  doi     = {10.1001/jamanetworkopen.2025.29665},
  pmid    = {40880087},
  url     = {https://doi.org/10.1001/jamanetworkopen.2025.29665}
}

@article{jain2025-41213043,
  author  = {Jain, Sneha S. and Sun, Tony and Pierson, Emma and Oliver, Francisco Roedan and Malta, Paloma P and Castillo, Michelle and Wan, Ningxin and Alishetti, Shudhanshu and others},
  title   = {{Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence}},
  journal = {JAMA Cardiology},
  year    = {2025},
  doi     = {10.1001/jamacardio.2025.4591},
  pmid    = {41213043},
  url     = {https://doi.org/10.1001/jamacardio.2025.4591}
}

@article{wang2020-32920628,
  author  = {Wang, H. Y. and Pei, Z. and Lee, K. C. and Lopez-Brignoni, E. and Nikolov, B. and Crowley, C. A. and Marsman, M. R. and Barbier, R. and others},
  title   = {{PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2020},
  doi     = {10.14283/jpad.2020.6},
  pmid    = {32920628},
  url     = {https://doi.org/10.14283/jpad.2020.6}
}

@article{collins2026-42565262,
  author  = {Collins, E. C. and Lu, M. and Beck, R. and Hendrix, J. and Hodsdon, M. E. and Hansson, O.},
  title   = {{Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026},
  doi     = {10.1002/alz.71740},
  pmid    = {42565262},
  url     = {https://doi.org/10.1002/alz.71740}
}

@article{ross2022-35344024,
  author  = {Ross, E. L. and Weinberg, M. S. and Arnold, S. E.},
  title   = {{Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.0315},
  pmid    = {35344024},
  url     = {https://doi.org/10.1001/jamaneurol.2022.0315}
}

@article{bayer2005-15642910,
  author  = {Bayer, A. J. and Bullock, R. and Jones, R. W. and Wilkinson, D. and Paterson, K. R. and Jenkins, L. and Millais, S. B. and Donoghue, S.},
  title   = {{Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD}},
  journal = {Neurology},
  year    = {2005},
  doi     = {10.1212/01.wnl.0000148604.77591.67},
  pmid    = {15642910},
  url     = {https://doi.org/10.1212/01.wnl.0000148604.77591.67}
}

@article{schneider2019-31282954,
  author  = {Schneider, L. S. and Thomas, R. G. and Hendrix, S. and Rissman, R. A. and Brewer, J. B. and Salmon, D. P. and Oltersdorf, T. and Okuda, T. and others},
  title   = {{Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1868},
  pmid    = {31282954},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1868}
}

@article{cummings2023-37251912,
  author  = {Cummings, J. and Zhou, Y. and Lee, G. and Zhong, K. and Fonseca, J. and Cheng, F.},
  title   = {{Alzheimer's disease drug development pipeline: 2023}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2023},
  doi     = {10.1002/trc2.12385},
  pmid    = {37251912},
  url     = {https://doi.org/10.1002/trc2.12385}
}

@article{timko2026-41931297,
  author  = {Timko, Noah J. and Wright, Mary Cooter and Reese, Melody A. and Boykin, Piper C. and Emerson, Jacqueline M. and Woldorff, Marty G. and Eleswarpu, Sarada and Herbert, J. Taylor and others},
  title   = {{Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients}},
  journal = {JAMA Network Open},
  year    = {2026},
  doi     = {10.1001/jamanetworkopen.2026.2289},
  pmid    = {41931297},
  url     = {https://doi.org/10.1001/jamanetworkopen.2026.2289}
}

@article{assogna2025-40046339,
  author  = {Assogna, Martina and Di Lorenzo, Francesco and Bonnı̀, Sonia and Borghi, Ilaria and Irelli, Emanuele Cerulli and Mencarelli, Lucia and Maiella, Michele and Minei, Marilena and others},
  title   = {{Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients}},
  journal = {Brain Communications},
  year    = {2025},
  doi     = {10.1093/braincomms/fcaf080},
  pmid    = {40046339},
  url     = {https://doi.org/10.1093/braincomms/fcaf080}
}

@article{betz2021-34550082,
  author  = {Betz, M. E. and Polzer, E. and Nearing, K. and Knoepke, C. E. and Johnson, R. L. and Meador, L. and Matlock, D. D.},
  title   = {{Feasibility and Acceptability of a Web-Based Caregiver Decision Aid (Safety in Dementia) for Firearm Access: Pilot Randomized Controlled Trial}},
  journal = {JMIR formative research},
  year    = {2021},
  doi     = {10.2196/30990},
  pmid    = {34550082},
  url     = {https://doi.org/10.2196/30990}
}

@article{valentisoler2015-26388764,
  author  = {Valentí Soler, M. and Agüera-Ortiz, L. and Olazarán Rodríguez, J. and Mendoza Rebolledo, C. and Pérez Muñoz, A. and Rodríguez Pérez, I. and Osa Ruiz, E. and Barrios Sánchez, A. and others},
  title   = {{Social robots in advanced dementia}},
  journal = {Frontiers in aging neuroscience},
  year    = {2015},
  doi     = {10.3389/fnagi.2015.00133},
  pmid    = {26388764},
  url     = {https://doi.org/10.3389/fnagi.2015.00133}
}

@article{torresyaghi2025-41286676,
  author  = {Torres-Yaghi, Y. and Chrones, L. and Abler, V. and Brunson, G.},
  title   = {{Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study}},
  journal = {BMC Neurology},
  year    = {2025},
  doi     = {10.1186/s12883-025-04496-8},
  pmid    = {41286676},
  url     = {https://doi.org/10.1186/s12883-025-04496-8}
}

@article{kim2022-35260170,
  author  = {Kim, J. and Yon, D. K. and Choi, K. Y. and Lee, J. J. and Kim, N. and Lee, K. H. and Kim, J. G.},
  title   = {{Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-00978-w},
  pmid    = {35260170},
  url     = {https://doi.org/10.1186/s13195-022-00978-w}
}

@article{maczurek2008-18655815,
  author  = {Maczurek, A. and Hager, K. and Kenklies, M. and Sharman, M. and Martins, R. and Engel, J. and Carlson, D. A. and Münch, G.},
  title   = {{Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease}},
  journal = {Advanced drug delivery reviews},
  year    = {2008},
  doi     = {10.1016/j.addr.2008.04.015},
  pmid    = {18655815},
  url     = {https://doi.org/10.1016/j.addr.2008.04.015}
}

@article{pagan2025-40565990,
  author  = {Pagán, Fernando and Torres-Yaghi, Yasar A. and Hebron, Michaeline L. and Wilmarth, Barbara and Turner, Raymond Scott and Matar, Sara and Liu, Xiaoguang and Ferrante, Dalila and others},
  title   = {{Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib}},
  journal = {Journal of Clinical Medicine},
  year    = {2025},
  doi     = {10.3390/jcm14124245},
  pmid    = {40565990},
  url     = {https://doi.org/10.3390/jcm14124245}
}

@article{dickerson2013-24130528,
  author  = {Dickerson, B. C. and Wolk, D. A. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau}},
  journal = {Frontiers in aging neuroscience},
  year    = {2013},
  doi     = {10.3389/fnagi.2013.00055},
  pmid    = {24130528},
  url     = {https://doi.org/10.3389/fnagi.2013.00055}
}

@article{vitek2023-36749830,
  author  = {Vitek, G. E. and Decourt, B. and Sabbagh, M. N.},
  title   = {{Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease}},
  journal = {Expert opinion on investigational drugs},
  year    = {2023},
  doi     = {10.1080/13543784.2023.2178414},
  pmid    = {36749830},
  url     = {https://doi.org/10.1080/13543784.2023.2178414}
}

@article{cupido2022-35921096,
  author  = {Cupido, A. J. and Reeskamp, L. F. and Hingorani, A. D. and Finan, C. and Asselbergs, F. W. and Hovingh, G. K. and Schmidt, A. F.},
  title   = {{Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study}},
  journal = {JAMA cardiology},
  year    = {2022},
  doi     = {10.1001/jamacardio.2022.2333},
  pmid    = {35921096},
  url     = {https://doi.org/10.1001/jamacardio.2022.2333}
}

@article{tunali2025-40081955,
  author  = {Tunali, Ilke and Wang, Jian and Arora, Anupa and Kim, Min Jung and Shcherbinin, Sergey and Pontecorvo, Michael J. and Iaccarino, Leonardo},
  title   = {{Development and Validation of a 18 F-Flortaucipir PET Visual Stratification Method}},
  journal = {Journal of Nuclear Medicine},
  year    = {2025},
  doi     = {10.2967/jnumed.124.268700},
  pmid    = {40081955},
  url     = {https://doi.org/10.2967/jnumed.124.268700}
}

@article{yokokura2011-20844871,
  author  = {Yokokura, M. and Mori, N. and Yagi, S. and Yoshikawa, E. and Kikuchi, M. and Yoshihara, Y. and Wakuda, T. and Sugihara, G. and others},
  title   = {{In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease}},
  journal = {European journal of nuclear medicine and molecular imaging},
  year    = {2011},
  doi     = {10.1007/s00259-010-1612-0},
  pmid    = {20844871},
  url     = {https://doi.org/10.1007/s00259-010-1612-0}
}

@article{yu2025-40840993,
  author  = {Yu, Congcong and Yang, Huijie and Zhang, Bing and Chen, Shihua and Yang, Sijue and Li, Fangyi and Zhu, Wenhui and Zhai, Beibei and others},
  title   = {{Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase}},
  journal = {BMJ Open},
  year    = {2025},
  doi     = {10.1136/bmjopen-2024-095382},
  pmid    = {40840993},
  url     = {https://doi.org/10.1136/bmjopen-2024-095382}
}

@article{smedinga2021-32809153,
  author  = {Smedinga, M. and Darweesh, S. K. L. and Bloem, B. R. and Post, B. and Richard, E.},
  title   = {{Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field}},
  journal = {Journal of neurology},
  year    = {2021},
  doi     = {10.1007/s00415-020-10162-5},
  pmid    = {32809153},
  url     = {https://doi.org/10.1007/s00415-020-10162-5}
}

@article{wischik2014-24361915,
  author  = {Wischik, C. M. and Harrington, C. R. and Storey, J. M.},
  title   = {{Tau-aggregation inhibitor therapy for Alzheimer's disease}},
  journal = {Biochemical pharmacology},
  year    = {2014},
  doi     = {10.1016/j.bcp.2013.12.008},
  pmid    = {24361915},
  url     = {https://doi.org/10.1016/j.bcp.2013.12.008}
}

@article{weber2020-31959733,
  author  = {Weber, G. E. and Koenig, K. A. and Khrestian, M. and Shao, Y. and Tuason, E. D. and Gramm, M. and Lal, D. and Leverenz, J. B. and others},
  title   = {{An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report}},
  journal = {Journal of immunology (Baltimore, Md. : 1950)},
  year    = {2020},
  doi     = {10.4049/jimmunol.1901166},
  pmid    = {31959733},
  url     = {https://doi.org/10.4049/jimmunol.1901166}
}

@article{khartabil2025-39998021,
  author  = {Khartabil, N. and Awaness, A.},
  title   = {{Targeting Amyloid Pathology in Early Alzheimer's: The Promise of Donanemab-Azbt}},
  journal = {Pharmacy (Basel, Switzerland)},
  year    = {2025},
  doi     = {10.3390/pharmacy13010023},
  pmid    = {39998021},
  url     = {https://doi.org/10.3390/pharmacy13010023}
}

@article{meier2018-29853653,
  author  = {Meier, SR. and Syvänen, S. and Hultqvist, G. and Fang, X. T. and Roshanbin, S. and Lannfelt, L. and Neumann, U. and Sehlin, D.},
  title   = {{Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2018},
  doi     = {10.2967/jnumed.118.213140},
  pmid    = {29853653},
  url     = {https://doi.org/10.2967/jnumed.118.213140}
}

@article{jeppsson2012-23048024,
  author  = {Jeppsson, F. and Eketjäll, S. and Janson, J. and Karlström, S. and Gustavsson, S. and Olsson, L. L. and Radesäter, A. C. and Ploeger, B. and others},
  title   = {{Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease}},
  journal = {The Journal of biological chemistry},
  year    = {2012},
  doi     = {10.1074/jbc.m112.409110},
  pmid    = {23048024},
  url     = {https://doi.org/10.1074/jbc.m112.409110}
}

@article{polito2026-41669531,
  author  = {Polito, Cristina and Martinelli, Giulia and Della Bella, Sara and Pavan, Eleonora and Crocetto, Ylenia and Abagnale, Simona and Rondoni, Cristiana and Voscarelli, Alfonso and others},
  title   = {{Integrated bio-cooperative robotic platform for virtual cognitive training in Parkinson's disease: design and methodology of the OPERA project}},
  journal = {Frontiers in Neurology},
  year    = {2026},
  doi     = {10.3389/fneur.2025.1680215},
  pmid    = {41669531},
  url     = {https://doi.org/10.3389/fneur.2025.1680215}
}

@article{cummings2025-41145337,
  author  = {Cummings, Jeffrey L. and Burstein, Aaron H. and Fillit, Howard M.},
  title   = {{Alzheimer Combination Therapies: Overview and Scenarios}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100328},
  pmid    = {41145337},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100328}
}

@article{howard2025-40536945,
  author  = {Howard, Calvin and Johnson, Amy M and Peedicail, Joseph Samuel and Ng, Marcus},
  title   = {{The Rapid Online Cognitive Assessment for the Detection of Neurocognitive Disorder: Open-Label Study}},
  journal = {Journal of Medical Internet Research},
  year    = {2025},
  doi     = {10.2196/66735},
  pmid    = {40536945},
  url     = {https://doi.org/10.2196/66735}
}

@article{davies1997-9258891,
  author  = {Davies, T. A. and Long, H. J. and Sgro, K. and Rathbun, W. H. and McMenamin, M. E. and Seetoo, K. and Tibbles, H. and Billingslea, A. M. and others},
  title   = {{Activated Alzheimer disease platelets retain more beta amyloid precursor protein}},
  journal = {Neurobiology of aging},
  year    = {1997},
  doi     = {10.1016/s0197-4580(97)00013-4},
  pmid    = {9258891},
  url     = {https://doi.org/10.1016/s0197-4580(97)00013-4}
}

@article{chun2022-35184428,
  author  = {Chun, M. Y. and Lee, J. and Jeong, J. H. and Roh, J. H. and Oh, S. J. and Oh, M. and Oh, J. S. and others},
  title   = {{18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment}},
  journal = {Yonsei medical journal},
  year    = {2022},
  doi     = {10.3349/ymj.2022.63.3.259},
  pmid    = {35184428},
  url     = {https://doi.org/10.3349/ymj.2022.63.3.259}
}

@article{davtyan2019-31847886,
  author  = {Davtyan, H. and Hovakimyan, A. and Kiani Shabestari, S. and Antonyan, T. and Coburn, M. A. and Zagorski, K. and Chailyan, G. and Petrushina, I. and others},
  title   = {{Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice}},
  journal = {Alzheimer's research \& therapy},
  year    = {2019},
  doi     = {10.1186/s13195-019-0556-2},
  pmid    = {31847886},
  url     = {https://doi.org/10.1186/s13195-019-0556-2}
}

@article{cline2025-39955261,
  author  = {Cline, Erika N. and Antwi‐Berko, Daniel and Sundell, Karen L. and Johnson, Elizabeth A. and Hyland, Maddelyn and Zhang, Hao and Vanderstichele, Hugo and Kaplow, June M. and others},
  title   = {{Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100082},
  pmid    = {39955261},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100082}
}

@article{malhotra2025-41543360,
  author  = {Malhotra, Chetna and Yue, Yanzhen and Ramakrishnan, Chandrika and Shah, Shimoni Urvish and Chen, Wenda and Yap, Philip Lin Kiat and Cheong, Chin Yee and Teo, Irene and others},
  title   = {{Supporting Dementia Caregiving With a Mobile Care Ecosystem: Development and Mixed Methods Study}},
  journal = {JMIR Aging},
  year    = {2025},
  doi     = {10.2196/78759},
  pmid    = {41543360},
  url     = {https://doi.org/10.2196/78759}
}

@article{rhodus2025-40621818,
  author  = {Rhodus, Elizabeth K. and Kryscio, Richard and Jicha, Gregory A. and Baum, Carolyn Manville and Henley, Laura and Fairchild, Vickie and Roberts, Celeste and Gibson, Allison},
  title   = {{Creating harmony at home via environmental cueing: A feasibility trial of a non‐pharmacological intervention for rural caregivers of persons with dementia}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70405},
  pmid    = {40621818},
  url     = {https://doi.org/10.1002/alz.70405}
}

@article{bhagunde2026-41543367,
  author  = {Bhagunde, Pratik R. and Penner, Natasha and Willis, Brian A. and Bell, Robert and Charil, Arnaud and Irizarry, Michael C. and Hersch, Steven J. and Reyderman, Larisa},
  title   = {{Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR ‐ SB Utilizing Semi‐Mechanistic Model}},
  journal = {CPT Pharmacometrics \& Systems Pharmacology},
  year    = {2026},
  doi     = {10.1002/psp4.70173},
  pmid    = {41543367},
  url     = {https://doi.org/10.1002/psp4.70173}
}

@article{wang2025-40911712,
  author  = {Wang, Guoqiao and Li, Yan and McDade, Eric and Xiong, Chengjie and Hartz, Sarah M. and Bateman, Randall John and Morris, John C. and Schneider, Lon S. S. and others},
  title   = {{Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70643},
  pmid    = {40911712},
  url     = {https://doi.org/10.1002/alz.70643}
}

@article{fitzgerald2025-41414790,
  author  = {Fitzgerald, Kathryn W. and Fyfe, Katrina P. and Thompson, Sandra Claire},
  title   = {{Development of a Rural and Remote Dementia Training Framework}},
  journal = {Australian Journal of Rural Health},
  year    = {2025},
  doi     = {10.1111/ajr.70133},
  pmid    = {41414790},
  url     = {https://doi.org/10.1111/ajr.70133}
}

@article{raja2026-d1c44bbc,
  author  = {Raja, Michelle and Patel, Khush and Krish, Pranav and Chow, Chrissy and Azam, Zaki},
  title   = {{GLP-1 Receptor Agonists Beyond Glycemic Control: Clinical Implications in Neurodegenerative Disease and Substance Use Disorders}},
  journal = {Journal of Community Hospital Internal Medicine Perspectives},
  year    = {2026},
  doi     = {10.55729/2000-9666.1651},
  url     = {https://doi.org/10.55729/2000-9666.1651}
}

@article{dirks2025-41451623,
  author  = {Dirks, Bryan and Friend, Samantha and Howell, Becky and Murphy, Christine M and Zhang, Peter M and Feng, Xiaoshu and Pathak, Sanjeev S},
  title   = {{Plasma Biomarker Characterization of Alzheimer’s Disease Psychosis in Study ACP‐204‐006}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_106556},
  pmid    = {41451623},
  url     = {https://doi.org/10.1002/alz70859_106556}
}

@article{zanjani2025-40223630,
  author  = {Zanjani, Faika A. K. and Rhodes, Annie and O'Donnell, Kennedy and Hawks, Cate and Boling, Peter A. and Slattum, Patricia W. and Price, Elvin T. and Parsons, Pamela L. and others},
  title   = {{Community Input for Addressing Dementia Health Disparities: Richmond Brain Health Initiative}},
  journal = {Progress in community health partnerships},
  year    = {2025},
  doi     = {10.1353/cpr.2025.a956599},
  pmid    = {40223630},
  url     = {https://doi.org/10.1353/cpr.2025.a956599}
}

@article{doherty2022-35622461,
  author  = {Doherty, T. and Gee, M. and Maruff, P. and Smith, R. and Murphy, J. and Marsh, J. and Koschalka, L. and Martinez, M. and others},
  title   = {{Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2022},
  doi     = {10.1097/wad.0000000000000508},
  pmid    = {35622461},
  url     = {https://doi.org/10.1097/wad.0000000000000508}
}

@article{ishibashi2025-40108731,
  author  = {Ishibashi, Kenji and Kurihara, Masanori and Ihara, Ryoko},
  title   = {{Both Amyloid and Tau Assessments Are Desired Before Initiating Disease-modifying Therapy for Alzheimer Disease: Three Real-world Cases}},
  journal = {Clinical Nuclear Medicine},
  year    = {2025},
  doi     = {10.1097/rlu.0000000000005842},
  pmid    = {40108731},
  url     = {https://doi.org/10.1097/rlu.0000000000005842}
}

@article{mulhern2013-23402232,
  author  = {Mulhern, B. and Rowen, D. and Brazier, J. and Smith, S. and Romeo, R. and Tait, R. and Watchurst, C. and Chua, K. C. and others},
  title   = {{Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation}},
  journal = {Health technology assessment (Winchester, England)},
  year    = {2013},
  doi     = {10.3310/hta17050},
  pmid    = {23402232},
  url     = {https://doi.org/10.3310/hta17050}
}

@article{day2022-35197360,
  author  = {Day, G. S. and Scarmeas, N. and Dubinsky, R. and Coerver, K. and Mostacero, A. and West, B. and Wessels, SR. and Armstrong, M. J.},
  title   = {{Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus [RETIRED]: A Report of the AAN Guidelines Subcommittee}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000200176},
  pmid    = {35197360},
  url     = {https://doi.org/10.1212/wnl.0000000000200176}
}